Latest Articles

Publication Date
All News Scientific
Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress - The Manila Times

Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress The Manila Times

Published: Nov. 10, 2025, 2:19 a.m.
Read Full Article
ASCENT-Gyn-01 Trial of Sacituzumab Govitecan Aims to Validate Clinical Utility of TROP2 ADCs in Pretreated Endometrial Cancer - OncLive

ASCENT-Gyn-01 Trial of Sacituzumab Govitecan Aims to Validate Clinical Utility of TROP2 ADCs in Pretreated Endometrial Cancer OncLive

Published: Sept. 26, 2025, 7:40 p.m.
Read Full Article
Immunohistochemical examination of CD163 and TROP2 expression levels in ovarian endometriosis.

Published: Aug. 22, 2025, midnight
Read Full Article
CD163 Endometriosis Immunohistochemistry Ovarian endometriosis TROP2
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!